Study Tests Flu Vaccines With Experimental Adjuvants

August 14, 2019

A clinical study by the National Institutes of Health will evaluate two seasonal flu vaccines with and without adjuvants, which are compounds that create stronger and longer-lasting immune responses when added to vaccines. 

The effectiveness of flu vaccination varies from year to year, and the adjuvant study is part of an NIH effort to create more durable flu vaccines. 

“We hope this trial will increase our understanding of how adjuvants could help confer better protection from seasonal influenza,” says Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases. 

Read the full press release.